INCREASED LEVELS OF SERUM PARATHYROID HORMONE AND FIBROBLAST GROWTH FACTOR-23 ARE THE MAIN FACTORS ASSOCIATED WITH THE PROGRESSION OF VASCULAR CALCIFICATION IN LONG-HOUR HEMODIALYSIS PATIENTS

被引：0
|
作者：
Jean, Guillaume [1 ]
Bresson, Eric [2 ]
Chazot, Charles [3 ]
机构：
[1] Nephrocare Tassin Charcot France, Sainte Foy Les Lyon, France
[2] Clin Protestante Caluire France, Lyon Caluire, France
[3] Nephrocate Tassin Charcot France, Sainte Foy Les Lyon, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [21] Higher serum Metrnl levels are associated with increased vascular calcification in hemodialysis patients
    Liu, Conghui
    Ren, Wenwen
    Zhang, Aihua
    RENAL FAILURE, 2025, 47 (01)
  • [22] ASSOCIATION BETWEEN FIBROBLAST GROWTH FACTOR-23 AND VASCULAR CALCIFICATION IN ATHLETIC PATIENTS: A META-ANALYSIS
    Luo, Yan-Kun
    Liu, Huan
    Chen, Ye
    Li, Rong-Shan
    Zhou, Yun
    REVISTA INTERNACIONAL DE MEDICINA Y CIENCIAS DE LA ACTIVIDAD FISICA Y DEL DEPORTE, 2024, 24 (95): : 524 - 537
  • [23] Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients
    Fukasawa, Hirotaka
    Ishigaki, Sayaka
    Kinoshita-Katahashi, Naoko
    Niwa, Hiroki
    Yasuda, Hideo
    Kumagai, Hiromichi
    Furuya, Ryuichi
    NEPHROLOGY, 2014, 19 (12) : 784 - 790
  • [24] Fibroblast Growth Factor-23 and Parathyroid Hormone Are Associated with Post-Transplant Bone Mineral Density Loss
    Kanaan, Nada
    Claes, Kathleen
    Devogelaer, Jean-Pierre
    Vanderschueren, Dirk
    Depresseux, Genevieve
    Goffin, Eric
    Evenepoel, Pieter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (10): : 1887 - 1892
  • [25] THE CLINICAL IMPACT OF FIBROBLAST GROWTH FACTOR 23 AND SCLEROSTIN ON VASCULAR CALCIFICATION IN PREVALENT HEMODIALYSIS PATIENTS
    Kuo, Mei-Chuan
    Lin, Yi-Ting
    Wu, Ping-Hsun
    Chiu, Yi-Wen
    Hwang, Shang-Jhy
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [26] The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis
    Nitta, K
    Akiba, T
    Uchida, K
    Kawashima, A
    Yumura, W
    Kabaya, T
    Nihei, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (02) : 303 - 309
  • [27] Increased serum fibroblast growth factor-23 (FGF-23) and bone turnover in patients with osteoarthritis of knee
    Zhou, Wu
    Liu, Guo-Hui
    Yang, Shu-Hua
    Ye, Shu-Nan
    Wang, Jing
    Liu, Xian-Zhe
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1630 - 1638
  • [28] Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
    Nakanishi, S
    Kazama, JJ
    Nii-Kono, T
    Omori, K
    Yamashita, T
    Fukumoto, S
    Gejyo, F
    Shigematsu, T
    Fukagawa, M
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 1171 - 1178
  • [29] Compensatory elevated serum intermedin levels are associated with increased vascular calcification in hemodialysis patients
    Wenhan Bao
    Lian He
    Aihua Zhang
    International Urology and Nephrology, 2022, 54 : 3001 - 3007
  • [30] Compensatory elevated serum intermedin levels are associated with increased vascular calcification in hemodialysis patients
    Bao, Wenhan
    He, Lian
    Zhang, Aihua
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (11) : 3001 - 3007
12345